Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed, Refractory Multiple Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01592370
What this trial is testing

An Investigational Immuno-Therapy Study to Determine the Safety and Effectiveness of Nivolumab and Daratumumab in Patients With Multiple Myeloma

Who this might be right for
Non-Hodgkin's LymphomaHodgkin LymphomaMultiple Myeloma
Bristol-Myers Squibb 320
Not applicableTemporarily pausedNCT03752541
What this trial is testing

Efficacy and Safety Evaluation of BCMA-UCART

Who this might be right for
Multiple Myeloma
Bioray Laboratories 20
Early research (Phase 1)UnknownNCT03672253
What this trial is testing

CAR-T Re-treatment for Refractory/Relapsed Multiple Myeloma

Who this might be right for
Multiple MyelomaMultiple Myeloma in RelapseMultiple Myeloma Progression
Second Affiliated Hospital of Xi'an Jiaotong University 20
Early research (Phase 1)Ended earlyNCT05121103
What this trial is testing

The Safety, Tolerability and Effectiveness of EZM0414 (IPN60210) Investigative Product in Participants With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Multiple Myeloma, RefractoryDiffuse Large B-Cell LymphomaDiffuse Large B Cell Lymphoma Refractory+1 more
Epizyme, Inc. 13
Testing effectiveness (Phase 2)Ended earlyNCT01315873
What this trial is testing

Bortezomib and Bendamustine to Treat Relapsed/Refractory Myeloma

Who this might be right for
Multiple Myeloma
NYU Langone Health 24
Large-scale testing (Phase 3)Ended earlyNCT04649060
What this trial is testing

Study of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple Myeloma

Who this might be right for
Relapsed Multiple MyelomaRelapsed-Refractory Multiple Myeloma
Oncopeptides AB 54
Testing effectiveness (Phase 2)UnknownNCT03605056
What this trial is testing

Phase 2 Trial of Chidamide-Lenalidomide-Dexamethasone(CRD) Regimen in R/R MM

Who this might be right for
Multiple Myeloma
Peng Liu 25
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Early research (Phase 1)Study completedNCT00891137
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Cellerant Therapeutics 30
Large-scale testing (Phase 3)Looking for participantsNCT07772024
What this trial is testing

Inobrodib, Pomalidomide and Dexamethasone Versus Standard Available Therapy in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma RefractoryMultiple Myeloma in Relapse
CellCentric Ltd. 450
Large-scale testing (Phase 3)Active Not RecruitingNCT06208150
What this trial is testing

A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 838
Testing effectiveness (Phase 2)Study completedNCT02206425
What this trial is testing

Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Oncotherapeutics 45
Testing effectiveness (Phase 2)Study completedNCT00809276
What this trial is testing

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

Who this might be right for
LymphomaMultiple MyelomaLeukemia+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 92
Early research (Phase 1)UnknownNCT05201118
What this trial is testing

A Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refractory Extramedullary Multiple Myeloma

Who this might be right for
Extramedullary Multiple Myeloma
Chunrui Li 20
Testing effectiveness (Phase 2)Study completedNCT01168804
What this trial is testing

Bendamustine Plus Bortezomib Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Austrian Forum Against Cancer 79
Post-approval studies (Phase 4)Study completedNCT03934684
What this trial is testing

Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed Refractory Multiple Myeloma
Amgen 101
Early research (Phase 1)Study completedNCT03489525
What this trial is testing

MEDI2228 in Subjects With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
MedImmune LLC 107
Early research (Phase 1)Study completedNCT01372540
What this trial is testing

Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Who this might be right for
Plasma Cell LeukemiaRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
M.D. Anderson Cancer Center 76
Early research (Phase 1)Ended earlyNCT05839626
What this trial is testing

Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA)

Who this might be right for
Relapsed/Refractory Multiple MyelomaAmyloid Light-chain Amyloidosis
Sanofi 32
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Next Page